Literature DB >> 540044

Metabolic oxidation of the ethynyl group in 4-ethynylbiphenyl.

A Wade, A M Symons, L Martin, D V Parke.   

Abstract

1. 4-Ethynylbiphenyl undergoes extensive metabolism in the rat and the rabbit, involving aromatic hydroxylation and oxidation of the ethynyl group. No metabolites containing the intact ethynyl group were detected. 2. In the rat unchanged 4-ethynylbiphenyl was concentrated initially in the adipose tissue. No other tissues accumulated significant amounts of radioactivity. 3. The major metabolites were the same in both the rat and the rabbit, namely 4'-hydroxybiphenyl-4-ylacetic acid (90-95% of dose) and biphenyl-4-ylacetic acid (2-10% of dose). 4. Excretion was slower in the rat than in the rabbit, probably because of greater biliary and faecal excretion in the rat. Biliary excretion and enterohepatic circulation of biphenyl-4-ylacetic acid and 4'-hydroxybiphenyl-4-ylacetic acid were demonstrated in the rat.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 540044      PMCID: PMC1161832          DOI: 10.1042/bj1840509

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  The use of non-ionic industrial detergents in liquid scintillation counting.

Authors:  P Wood; J English; J Chakraborty; R Hinton
Journal:  Lab Pract       Date:  1975-11

2.  The urinary metabolites of 17alpha-ethynylestradiol-9alpha,11xi-3H in women. Chromatographic profiling and indentification of ethynyl and non-ethynyl compounds.

Authors:  M C Williams; E D Helton; J W Goldzieher
Journal:  Steroids       Date:  1975-02       Impact factor: 2.668

3.  The metabolism of biphenyl. II. Phenolic metabolites in the rat.

Authors:  T Meyer; R R Scheline
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976

4.  The metabolism of biphenyl. I. Metabolic disposition of 14C-biphenyl in the rat.

Authors:  T Meyer; J Aabakke; R R Scheline
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976

5.  Human urinary and liver conjugates of 17alpha-ethnylestradiol.

Authors:  E D Helton; M C Williams; J W Goldzieher
Journal:  Steroids       Date:  1976-06       Impact factor: 2.668

6.  The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds.

Authors:  P J Creaven; D V Parke
Journal:  Biochem Pharmacol       Date:  1966-01       Impact factor: 5.858

7.  Studies on the metabolism of ethynylestradiol in vitro and in vivo: the significance of 2-hydroxylation and the formation of polar products.

Authors:  H M Bolt; H Kappus; H Remmer
Journal:  Xenobiotica       Date:  1973-12       Impact factor: 1.908

8.  Sex hormones and hepatic neoplasia.

Authors:  S Goldfarb
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

9.  Metabolism of 2-3H- and 4-14C-17alpha-ethynylestradiol 3-methyl ether (mestranol) by women.

Authors:  J G Williams; K I Williams
Journal:  Steroids       Date:  1975-12       Impact factor: 2.668

10.  Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem.

Authors:  I N White
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

View more
  4 in total

Review 1.  Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.

Authors:  Paul R Ortiz de Montellano
Journal:  Drug Metab Rev       Date:  2019-07-07       Impact factor: 4.518

2.  The metabolic oxidation of the ethynyl group in 4-ethynylbiphenyl in vitro.

Authors:  A Wade; A M Symons; L Martin; D V Parke
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

3.  Metabolic activation of acetylenes. Covalent binding of [1,2-14C]octyne to protein, DNA and haem in vitro and the protective effects of certain thiol compounds.

Authors:  I N White; J B Campbell; P B Farmer; E Bailey; N H Nam; D C Thang
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

4.  Suicidal destruction of cytochrome p-450 by ethynyl substituted compounds.

Authors:  I N White
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.